Press Release

Global Hereditary Orotic Aciduria Treatment Market Expected to Grow at a Healthy Pace During 2024-2032, Driven by Constant Innovation in the Industry

Global Hereditary Orotic Aciduria Treatment Market

According to a new report by EMR titled, 'Global Hereditary Orotic Aciduria Treatment Market Report and Forecast 2024-2032', the global market for hereditary orotic aciduria treatment is being aided by the growing clinical trial services market, which is expected to grow at a CAGR of 8% in the forecast period of 2024-2032.

Hereditary orotic aciduria is a unique, potentially life-threatening, genetic disorder that hinders the synthesisation of adequate amounts of uridine in the patient, and results in suffering from hematologic abnormalities, a range of developmental delays, failure to thrive, and episodes of crystalluria resulting in obstructive uropathy.

 

The market is being driven by the constant innovation and launches by the key industry players, such as Merck & Co., Inc. (NYSE: MRK) and Wellstat Therapeutics Corporation. In September 2016, Wellstat Therapeutics Corporation announced that the US Food and Drug Administration (FDA) approved a treatment known as uridine triacetate (Xuriden) for hereditary orotic aciduria treatment. Along with the approval of XURIDEN for the medication of HOA, the FDA has also granted the company, Wellstat Therapeutics, a Rare Pediatric Disease Priority Review Voucher. XURIDEN was made available commercially in early 2016. The rising healthcare awareness is expected to further aid the market growth in the forecast period.

 

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis by Drug Type, Indication, Distribution Channel, and Region:

  • On the basis of indication, the industry is segmented into type I and type II, among others.
  • By distribution channel, the industry is categorised into hospital pharmacies, retail pharmacies, and online, among others.
  • Regionally, the market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Key Findings of the Report:

  • The industry is propelled by the rising cases of clinical trials to develop drugs that offer proper treatment of the disorder.
  • The market is further being aided by the significant proportion of patients being recovered by the use of uridine. 
  • The growing healthcare awareness and healthcare expenditure is expected to boost the market growth of hereditary orotic aciduria treatment.
  • Ongoing research and development within the pharmaceutical industry and molecular science are expected to support the market growth in the forecast period. 

 

Key Offerings of the Report:

  • The EMR report gives an overview of the global market for hereditary orotic aciduria treatment for the periods (2018-2023) and (2024-2032). 
  • The report also offers the historical (2018-2023) and forecast (2024-2032) for the drug types, indications, distribution channels, and regional markets of hereditary orotic aciduria treatment. 
  • The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

 

Merck & Co. Inc. and Wellstat Therapeutics Corporation, among others, are the key players in the global hereditary orotic aciduria treatment market. The EMR report looks into the capacity, market share, and latest developments of these major players like plant turnarounds, mergers and acquisitions, and capacity expansions.

 

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

 

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

 

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER